Get started

Cassava Sciences, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

SAVA chart

Key stats

Market capitalization
877.22MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.29USD
Net income
−76.246MUSD
Revenue
—
Shares float
39.564M
Beta
0.73

About Cassava Sciences, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Remi Barbier
Website
cassavasciences.com
Headquarters
Austin
Employees (FY)
26
Founded
1998
ISIN
US14817C1071
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Ideas

Almost time?Just stumbled on this chart earlier when searching for something else... No idea about the company, went to the website real quick something Alzheimer's blah blah blah... look i don't care, technically it looks cool. If we dip down to the support its a good risk/reward with a stop loss directly belo
Long
by MikeMM
4
SAVA - SHOULD IT RESPECT THE DEMAND ZONE ?I believe it filled the previous AUG 22 spike and created solid demand zone. It is currently closing just above it. In my watchlist for coming weeks and see if it reaches low of the demand zone and then evaluate/predict the next move the next move either to test the trendline line or break it down t
by BUMISHO
1
SAVA - Double BottomSlanted Double Bottom This can be also observed earlier in prices history, again along the strong horizontal in yellow which is the most important take away from this chart Bars pattern placed in green is just an example of how price could recover Bullish above the horizontal
by Bixley
Sava Made a YouTube video on this yeateday Came to conclusion of a potential sick trade If we can start holding 35.50 as support (best option could be a breakout of 36.55 ) We have huge support at 33$ and 32.45. Anything below 32.45 could cancel the bullish veiw Looks to be a symtrical triangle wi
Long
by Erictaylor
11
SAVA to 25 then maybe 14SAVA is forming a flat bottom wedge. Right now, its closer to resistance than to support (which is around 14 dollars). We should see it at 14 by (most likely) mid January. We may see a short bounce off 200 EMA , which is around 28 dollars
Short
by moazzamk
Swing trading on SAVA - 17-10-2022Hello everyone, 🌟 Here again Romluck with a new trading idea, The trading ideas I find are after searching and investing time. Thanks for the like and comment. "Cassava Sciences" : NASDAQ:SAVA Market Cap 1.55B Short Float 28.49%⛔️ Target Price 50$💰 What i see :👀 🔆triggering a possible bu
Long
by ROMLUCK
2
Cassava Rockets After SEC Reportedly Clears It Of TamperingSAVA:NASDAQ is one of those stocks that can get super spikey on news and after a 10 month investigation the SEC has apparently cleared them of any wrongdoing after having previously accused the company of manipulating research results of its experimental Alzheimers Disease drug. Feels overbought at
by zAngus
2

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers